|
The
Future of APS Is Now
Dennis
C. Turk, PhD, Immediate Past President
I recently
returned from APS’s extremely successful annual meeting in
San Antonio. I am renewed and invigorated, as I am sure all who
attended will agree.
During
the meeting, Past-President Chris Miaskowski and I shared with those
in attendance the newly approved mission statement of and vision
for APS. We also discussed the strategic plan for the next 3 years
and the status of the “Dream No Small Dreams” Campaign.
To listen to an audio recording of that session, please click
here.
For
the past 18 months, the board has gone through an extensive process
of self-evaluation, reflecting on the past and directions for the
future.
The
core values of any organization consist of a set of beliefs that
form its basic philosophy, spirit, and driving force for all thinking,
decision making, and actions. As the board proceeded, we agreed
that the core values of APS are leadership (in research, education,
practice, and policy), integrity, objectivity, integration, diversity,
and interdisciplinary emphasis. These have not changed since our
founding, and they will carry us forward into the future.
Tremendous
advances in knowledge have taken place since the founding of APS.
With new information about pain and the mechanisms involved—anatomy,
neurophysiology, neurochemistry, and psychology—comes an enlightened
vision, a vision to which we can aspire.
A
world where prevention and relief of pain-related suffering are
available to all people!
Our
mission supports our core values and attainment of our lofty vision.
To accomplish this vision, the board crafted a revised mission statement.
It reiterates who we are: “A multidisciplinary community
that brings together a diverse group of scientists, clinicians,
and other professionals.” And it states what we hope
to achieve: “To increase the knowledge of pain and
transform public policy and clinical practice to prevent or relieve
pain-related suffering.” Our new mission statement
supports APS’s position as a leader and shaper.
Core
values and a mission statement alone cannot move us toward our vision
of prevention and relief of pain-related suffering for all. Toward
that end, the board crafted an ambitious strategic plan, which holds
tremendous promise. Outlined below, the initiatives are organized
into four broad categories.
Policy
and Advocacy
-
Develop a proactive communication strategy to engage policy and
decision makers as well as the public.
-
Develop an ongoing presence to interact with decision makers being
proactive rather than reactive.
-
Collaborate on a regulatory summit to address balancing the roles
of clinicians and law enforcement in pain treatment.
Research
-
Increase funding for “young investigator” grants.
-
Advocate for increased NIH funding for pain research.
-
Create a task force on translational research.
Education
-
Expand new investigator and clinician programs.
-
Create an APS lecture series that communicates advances in our
science and practice to relevant organizations.
-
Develop a set of electronic versions of the Principles of
Analgesic Use in the Treatment of Acute Pain and Cancer Pain
to take advantage of new and advanced technologies.
-
Create a Center of Excellence in Pain Management program to acknowledge
best practices and bring visibility to outstanding programs.
You
will hear more about these initiatives over the next 3 years. These
activities will not replace the many ongoing APS initiatives, but
will complement them.
Reviewing
these intitiatives is inspiring and at times breathtaking. There
are at least two things that are required to move us toward our
vision—money and human resources. Much more can be done to
expand these resources and doing so will be an important target
as we attempt to realize our strategic plan.
Human
resources—That’s you and me. The strategic plan requires
people to carry out these initiatives. It cannot and will not be
successful unless each member becomes involved and commits time
and energy to the process.
I look
forward to the future with enthusiasm and keen anticipation. The
future of APS is now!
APS
Call for Symposia and Corporate Satellite Symposia
The
2007 APS Call for Symposia and Corporate Satellite Symposia has
been available online since May 31, 2006, at www.ampainsoc.org.
The submission deadline is July 26, 2006.
The
Call for Paper and Poster Abstracts will be available online beginning
September 1, 2006. The submission deadline for these abstracts is
October 27, 2006.
APS
2006 Future Leaders in Pain Small Research Grants Program
APS
is pleased to announce the second annual Future Leaders in Pain
Small Research Grants Program. This grant program was established
to fund research projects of doctorally prepared investigators who
have not yet attained NIH RO1 level funding. The program's intent
is to encourage research in pain that will add to the body of knowledge
and allow investigators to develop pilot data that will aid them
in securing additional major grant funding.
APS
gratefully acknowledges Cephalon, Inc., and Endo Pharmaceuticals
for their support of this program. With increased funding, APS is
able to make five grants of $20,000 each in 2006.
Proposed
research projects should be in one of the following five areas of
inquiry:
-
use of analgesic medications
-
unwanted effects of pain treatment related to analgesic therapy
-
neuropathic pain
-
mechanisms of pain
-
education and nonpharmacologic interventions or approaches to
improve pain management.
Applications
are due July 21, 2006. Grant awards will be announced September
15, 2006.
For
additional information, contact APS at 847/375-4715 or info@ampainsoc.org.
Call
for 2007 Awards Nominations
The
APS Awards Committee invites nominations for awards to be presented
at the 26th Annual Scientific Meeting, May 2–5, 2007, in Washington,
D.C. The committee solicits nominations for the following APS awards:
- John
and Emma Bonica Public Service Award
-
Wilbert E. Fordyce Clinical Investigator Award
-
F. W. L. Kerr Basic Science Research Award
-
Jeffrey Lawson Award for Advocacy in Children's Pain Relief
-
John C. Liebeskind Early Career Scholar Award
-
Elizabeth Narcessian Award
-
Distinguished Service Award
-
Kathleen M. Foley Journalist Award
All
nominations must be received by July 21, 2006. All members will
receive a brochure and a nomination form shortly in the mail.
NIH
Research Awards Information Search Engine
During
the recent May 2006 APS Board meeting, the board approved continuation
of funding for a project at the University of Utah to collect National
Institutes of Health (NIH) funding patterns for research on pain
and related topics. David Bradshaw, Yoshio Nakamura, and Richard
Chapman have developed an interactive information retrieval system
that permits description and exploration of NIH funding patterns
for research on pain and related topics. This system, NIH Research
Awards Information Search Engine (NIHRAISE), extends the capabilities
of the existing NIH public record system for grants, which only
permits simple searches for matching terms on a record-by-record
basis. NIHRAISE makes it possible to derive and analyze complex
NIH funding patterns for pain and related subjects. It summarizes
funding for specific areas of inquiry or particular institutes.
NIHRAISE
is a long-range effort with the following goals: (1) build and sustain
an evidence base on NIH funding for pain and related topics; (2)
make the evidence base available to users on the Internet; and (3)
publish reports of information derived from the evidence base. The
database will be updated annually and retrospective analyses will
be undertaken to uncover patterns of funding over the previous 5
years.
Although
the primary purpose of NIHRAISE is to permit evaluation of NIH funding
for pain research, it can also investigate funding for related topics
such as palliative care, symptom management, and functional disorders.
It is well suited for domains of inquiry that are inherently multidisciplinary
and that encompass basic science as well as clinical and epidemiological
research.
This
database will identify underfunded areas of pain research and ultimately
help policy makers and those who shape the future of pain research.
News
Highlights from The Journal of Pain
The
following highlights summarize selected articles from the May 2006
issue (volume 7, number 5) of The Journal of Pain.
Parent
and Child Anxiety Sensitivity, Relationship to Children’s
Experimental Pain Responsivity
Jennie C. I. Tsao, Qian Lu, Cynthia D. Myers, Su C. Kim, Norman
Turk, and Lonnie K. Zeltzer, Department of Pediatrics, David Geffen
School of Medicine at UCLA
Anxiety
sensitivity (AS) is the tendency to interpret anxiety sensations,
such as a rapid heartbeat, as a predictor of harmful outcomes. In
adult studies, this fear of anxiety sensations has been associated
with chronic pain and, in laboratory studies, women with high AS
have shown increased experimental pain sensitivity. Some retrospective
studies have found that childhood pain experiences correlate with
high AS in adults. Further, parental perceptions of pain may influence
how children perceive it. No studies to date have examined relationships
among parent AS (PAS), child AS (CAS), and children’s responses
to controlled pain stimuli.
For
this article, researchers evaluated 104 girls and 107 boys (mean
age 12.4) and 178 mothers. They tested a conceptual model in which
PAS would predict CAS. Thus, PAS would be related to child laboratory
pain intensity by its contribution to CAS. The model was validated
in girls but not boys. The authors noted their findings agree with
prior research reporting significant associations between parental
anxiety and child distress during painful medical procedures. They
concluded that a parental tendency to interpret anxiety symptoms
as dangerous may influence how healthy girls respond to painful
stimuli.
Hypervigilence
to Learned Pain Signals: A Componential Analysis
Stefaan Van Damme, Geert Crombez, Christopher Eccleston, and
Ernst H.W. Koster
Department of Psychology, Ghent University, Belgium
For
chronic pain patients, hypervigilance (attending to pain at the
expense of other information) intensifies avoidance and escape tendencies.
It emerges in anyone who is confronted with threatening pain and
wants to avoid or escape it. In this study, subjects exposed to
laboratory pain stimuli were evaluated to gain further understanding
of hypervigilance during their anticipation of pain. The researchers
concluded that hypervigilance emerged as enhanced engagement to
conditioned pain signals, difficulty disengaging attention from
conditioned pain signals, and rapidly responding to pain signals.
These
findings suggest that treatment approaches using attention techniques
should not focus on preventing patients from shifting their attention
to the pain, but on diminishing the threat value and learning to
disengage from their pain.
Does
Self-Efficacy Influence Leg Muscle Pain During Cycling Exercise?
Robert W. Motl, James F. Konopack, Liang Hu, and Edward McAuley
Department of Kinesiology and Community Health, University of Illinois
Little
is known about the psychological influences on muscle pain during
exercise. One reason to believe self-efficacy is a potential influence
on muscle pain is that it is considered to be inversely related
with ratings of perceived exertion during exercise. Also, there
is a moderate to strong correlation between perceptions of exertion
and muscle pain. The authors hypothesized that enhanced self-efficacy
would be associated with lower ratings of naturally occurring muscle
pain during exercise.
Twenty-eight
low or moderately active college-age women were randomly assigned
to two groups to increase or decrease efficacy beliefs for engaging
in moderate physical activity. Efficacy was manipulated with bogus
feedback after an exercise test. After 2–3 days, participants
completed 30 minutes of cycling on an ergometer.
The
researchers found that although bogus feedback was effective for
manipulating self-efficacy, there was no differential effect on
leg muscle pain intensity ratings in either group. The authors noted
these findings should not be generalized to other groups, such as
very physically active women and elite athletes.
NIH
Grant Opportunity: New Models of Pain Relevant to the Trigeminal
System (R01)
This funding opportunity seeks to stimulate research on chronic
orofacial pain disorders that will provide insights into the pathophysiological
mechanisms underlying these conditions and the biological mechanisms
underlying the analgesic treatments. Two major goals of this funding
opportunity are (1) to stimulate research on patients with chronic
painful disorders and (2) to stimulate the development and utilization
of novel animal models of chronic orofacial pain conditions. This
initiative also encourages the development of novel measures of
pain in patients and animals that are noninvasive and objective
and that permit a behavioral or functional assessment of pain. The
primary outcome of this initiative will be increased knowledge of
the biological mechanisms underlying chronic pain disorders, nociception,
and analgesic therapies. The application due date is November 21,
2006. For more information go to grants.nih.gov/grants/guide/rfa-files/RFA-DE-07-006.html.
Annual
Meeting CD-ROM
Did
you attend the annual meeting in San Antonio? Did you miss a session
that you would have liked to have attended? APS is pleased to announce
that it will be mailing an MP3 CD-ROM of all annual meeting sessions—over
40 hr of audio content—to those who attended the meeting.
Expect to receive your CD-ROM in late June!
APS
gratefully acknowledges Cephalon, Inc., for its generous support
of this product through an educational grant.
Call
for Abstracts: 4th Annual Headache Research Summit
The
National Headache Foundation (NHF) is sponsoring the 4th Annual
Headache Research Summit February 13–14, 2007. The Summit
will provide a forum for up-and-coming researchers and physicians
to present their findings. This program will attract a diverse audience
including physicians, midlevel providers, and researchers. The theme
for the 2007 Research Summit will be central sensitization (February
13) and clinical application (February 14). The deadline for abstract
submissions is November 15. Abstracts must be submitted electronically
to csmith@headaches.org. |